
Eproron 250mg Injection
Marketer
Kyna Pharmaceuticals
Salt Composition
Hydroxyprogesterone (250mg)
Overview Eproron 250mg Injection
Preterm labor prevention in pregnant women is the purpose of Eproron 250mg Injection. It reduces the likelihood of premature birth, particularly for those with a prior preterm delivery history, thereby decreasing the risk of miscarriage. Administration is strictly by, or under the direct guidance of, a physician. Dosage and duration are determined solely by your doctor, and the injection should be used only as prescribed. Common side effects include injection site reactions, nausea, itching, diarrhea, and rash. Report any bothersome effects to your physician; management strategies may be available. Blood sugar monitoring is essential due to potential glycemic effects. Immediately report jaundice (yellowing of eyes or skin), dark urine, or abdominal pain. Prior to commencing treatment, disclose any history of circulatory problems, diabetes, or liver disease to your doctor. Furthermore, complete disclosure of all other medications is crucial, as interactions could diminish Eproron's efficacy or alter its function.
Uses of Eproron 250mg Injection
Averting Preterm Birth
Major Benefits of Eproron 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Eproron 250mg Injection:
- Injection site pain
- Injection site swelling
- Red spots or bumps
- Rash
How to use Eproron 250mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Eproron 250mg Injection works:
Eproron Injection, 250mg strength, contains a progestational agent.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Eproron 250mg Injection may pose safety risks; physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Eproron, 250mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; however, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Eproron, at a 250mg dose, is considered safe for use while breastfeeding. Research in humans indicates minimal to negligible transfer of the drug into breast milk, posing no identified risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Eproron 250mg Injection.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Eproron 250mg Injection to individuals with renal impairment. Physician consultation is advised. The drug's progesterone component may induce fluid retention in patients suffering from pre-existing kidney conditions.
LiverUNSAFE
Individuals with liver impairment should likely avoid the use of Eproron 250mg Injection due to potential safety concerns. Medical advice is recommended.
What if you forget to take Eproron 250mg Injection :
Should you forget a dose of the Eproron 250mg injection, seek advice from your physician.
Facts to Know About Eproron 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Glucocorticoids, Mineralocorticoids, and Progestins |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Actions | First-generation Progestins |
